annual CAPEX:
$5.78M-$8.21M(-58.68%)Summary
- As of today (June 22, 2025), NTLA annual capital expenditures is $5.78 million, with the most recent change of -$8.21 million (-58.68%) on December 31, 2024.
- During the last 3 years, NTLA annual CAPEX has fallen by -$6.98 million (-54.70%).
- NTLA annual CAPEX is now -90.10% below its all-time high of $58.39 million, reached on December 31, 2022.
Performance
NTLA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$735.00K-$246.00K(-25.08%)Summary
- As of today (June 22, 2025), NTLA quarterly capital expenditures is $735.00 thousand, with the most recent change of -$246.00 thousand (-25.08%) on March 31, 2025.
- Over the past year, NTLA quarterly CAPEX has dropped by -$1.77 million (-70.67%).
- NTLA quarterly CAPEX is now -98.41% below its all-time high of $46.26 million, reached on March 31, 2022.
Performance
NTLA quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$4.01M-$1.77M(-30.65%)Summary
- As of today (June 22, 2025), NTLA TTM capital expenditures is $4.01 million, with the most recent change of -$1.77 million (-30.65%) on March 31, 2025.
- Over the past year, NTLA TTM CAPEX has dropped by -$8.65 million (-68.35%).
- NTLA TTM CAPEX is now -93.14% below its all-time high of $58.39 million, reached on December 31, 2022.
Performance
NTLA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
NTLA CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -58.7% | -70.7% | -68.3% |
| 3 y3 years | -54.7% | -98.4% | -92.9% |
| 5 y5 years | -14.9% | -13.0% | -34.4% |
NTLA CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -90.1% | at low | -98.4% | at low | -93.1% | at low |
| 5 y | 5-year | -90.1% | +61.2% | -98.4% | +5.3% | -93.1% | +11.8% |
| alltime | all time | -90.1% | +126.2% | -98.4% | +42.4% | -93.1% | +676.5% |
NTLA CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $735.00K(-25.1%) | $4.01M(-30.7%) |
| Dec 2024 | $5.78M(-58.7%) | $981.00K(-23.3%) | $5.78M(-8.5%) |
| Sep 2024 | - | $1.28M(+26.4%) | $6.32M(-32.6%) |
| Jun 2024 | - | $1.01M(-59.6%) | $9.37M(-26.0%) |
| Mar 2024 | - | $2.51M(+64.9%) | $12.66M(-9.5%) |
| Dec 2023 | $13.98M(-76.0%) | $1.52M(-64.9%) | $13.98M(-14.6%) |
| Sep 2023 | - | $4.33M(+0.7%) | $16.38M(+0.6%) |
| Jun 2023 | - | $4.30M(+12.2%) | $16.28M(+2.0%) |
| Mar 2023 | - | $3.83M(-2.0%) | $15.96M(-72.7%) |
| Dec 2022 | $58.39M(+357.7%) | $3.91M(-7.7%) | $58.39M(+1.8%) |
| Sep 2022 | - | $4.24M(+6.5%) | $57.35M(-0.5%) |
| Jun 2022 | - | $3.98M(-91.4%) | $57.65M(+1.8%) |
| Mar 2022 | - | $46.26M(+1513.0%) | $56.60M(+343.8%) |
| Dec 2021 | $12.76M(+255.8%) | $2.87M(-36.8%) | $12.76M(+17.1%) |
| Sep 2021 | - | $4.54M(+54.5%) | $10.89M(+54.4%) |
| Jun 2021 | - | $2.94M(+21.8%) | $7.05M(+36.9%) |
| Mar 2021 | - | $2.41M(+139.8%) | $5.15M(+43.7%) |
| Dec 2020 | $3.58M | $1.01M(+44.1%) | $3.58M(-30.4%) |
| Sep 2020 | - | $698.00K(-32.6%) | $5.15M(-16.9%) |
| Jun 2020 | - | $1.04M(+22.6%) | $6.20M(+1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $845.00K(-67.1%) | $6.11M(-10.1%) |
| Dec 2019 | $6.79M(+6.9%) | $2.57M(+47.1%) | $6.79M(+16.9%) |
| Sep 2019 | - | $1.75M(+85.8%) | $5.81M(-4.4%) |
| Jun 2019 | - | $941.00K(-38.6%) | $6.08M(+0.7%) |
| Mar 2019 | - | $1.53M(-3.7%) | $6.04M(-5.0%) |
| Dec 2018 | $6.36M(-37.0%) | $1.59M(-21.0%) | $6.36M(-11.2%) |
| Sep 2018 | - | $2.02M(+124.0%) | $7.16M(-3.3%) |
| Jun 2018 | - | $900.00K(-51.4%) | $7.41M(-4.8%) |
| Mar 2018 | - | $1.85M(-22.8%) | $7.78M(-22.9%) |
| Dec 2017 | $10.09M(+63.7%) | $2.40M(+6.1%) | $10.09M(-9.1%) |
| Sep 2017 | - | $2.26M(+77.7%) | $11.10M(+17.5%) |
| Jun 2017 | - | $1.27M(-69.4%) | $9.44M(+1.3%) |
| Mar 2017 | - | $4.16M(+22.2%) | $9.32M(+51.2%) |
| Dec 2016 | $6.17M(+141.4%) | $3.40M(+462.8%) | $6.17M(+70.8%) |
| Sep 2016 | - | $605.00K(-47.3%) | $3.61M(+0.1%) |
| Jun 2016 | - | $1.15M(+13.8%) | $3.61M(+18.4%) |
| Mar 2016 | - | $1.01M(+18.7%) | $3.05M(+19.3%) |
| Dec 2015 | $2.55M | $849.00K(+41.0%) | $2.55M(+49.8%) |
| Sep 2015 | - | $602.00K(+2.6%) | $1.71M(+54.6%) |
| Jun 2015 | - | $587.00K(+13.8%) | $1.10M(+113.8%) |
| Mar 2015 | - | $516.00K | $516.00K |
FAQ
- What is Intellia Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Intellia Therapeutics?
- What is Intellia Therapeutics annual CAPEX year-on-year change?
- What is Intellia Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Intellia Therapeutics?
- What is Intellia Therapeutics quarterly CAPEX year-on-year change?
- What is Intellia Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Intellia Therapeutics?
- What is Intellia Therapeutics TTM CAPEX year-on-year change?
What is Intellia Therapeutics annual capital expenditures?
The current annual CAPEX of NTLA is $5.78M
What is the all time high annual CAPEX for Intellia Therapeutics?
Intellia Therapeutics all-time high annual capital expenditures is $58.39M
What is Intellia Therapeutics annual CAPEX year-on-year change?
Over the past year, NTLA annual capital expenditures has changed by -$8.21M (-58.68%)
What is Intellia Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of NTLA is $735.00K
What is the all time high quarterly CAPEX for Intellia Therapeutics?
Intellia Therapeutics all-time high quarterly capital expenditures is $46.26M
What is Intellia Therapeutics quarterly CAPEX year-on-year change?
Over the past year, NTLA quarterly capital expenditures has changed by -$1.77M (-70.67%)
What is Intellia Therapeutics TTM capital expenditures?
The current TTM CAPEX of NTLA is $4.01M
What is the all time high TTM CAPEX for Intellia Therapeutics?
Intellia Therapeutics all-time high TTM capital expenditures is $58.39M
What is Intellia Therapeutics TTM CAPEX year-on-year change?
Over the past year, NTLA TTM capital expenditures has changed by -$8.65M (-68.35%)